Breast Implant CEO Slams SEC's Stock Fraud 'Scheme' Claim
A breast implant manufacturing executive denied that his "isolated omission" about defects at a company manufacturing plant constitutes what the government claims was a scheme to defraud investors, according to a...To view the full article, register now.
Already a subscriber? Click here to view full article